Masis Solano Marisse, Huang Guofu, Lin Shan C
Dev Ophthalmol. 2017;59:179-190. doi: 10.1159/000458496. Epub 2017 Apr 25.
Cyclodestructive procedures are traditionally used in cases of glaucoma that are refractory to medical and surgical therapy. The goal of this chapter is to describe the indications, contraindications, techniques, and pitfalls of cyclodestructive procedures, including transscleral cyclophotocoagulation (TCP), micropulse TCP (MP-TCP), endoscopic cyclophotocoagulation (ECP), and ultrasound cilioplasty.
A literature search for cyclodestructive techniques was performed, and relevant studies were included for evaluation and review.
It is encouraging that TCP seems relatively efficacious even for patients who have been refractory to other treatments, depending on the energy setting, follow-up period, and definition of success. Repeated TCP is often required. TCP was more often used in eyes with limited visual potential caused by severe forms of glaucoma than in eyes with good visual potential. Serious complications were significant vision loss, inflammation, hypotony, and phthisis. ECP came later into clinical use for the treatment of refractory glaucoma. ECP is able to specifically target the ciliary epithelium under direct viewing as compared to TCP, which is an indirect cyclodestructive procedure. In the literature, it has been demonstrated that ECP has overall good success with relatively low complication rates when used for adult forms of glaucoma. A new technology using MP-TCP is a promising alternative to conventional cyclophotocoagulation. Early evidence shows that MP-TCP has clinical utility and a good safety profile. Ultrasound cilioplasty is a possible alternative to laser cyclodestruction that is already being commercialized and is currently under investigation.
Both TCP and ECP are effective cyclodestructive procedures and alternatives for the treatment of glaucoma refractory to medical and surgical therapy, though potential for serious complications exists. TCP, ECP, and ultrasound cilioplasty are being used increasingly as the primary surgery for various kinds and stages of glaucoma.
传统上,睫状体破坏手术用于药物和手术治疗无效的青光眼病例。本章的目的是描述睫状体破坏手术的适应证、禁忌证、技术及陷阱,包括经巩膜睫状体光凝术(TCP)、微脉冲TCP(MP-TCP)、内镜睫状体光凝术(ECP)和超声睫状体成形术。
对睫状体破坏技术进行文献检索,并纳入相关研究进行评估和综述。
令人鼓舞的是,根据能量设置、随访时间和成功的定义,TCP即使对其他治疗无效的患者似乎也相对有效。通常需要重复进行TCP。与视力良好的眼睛相比,TCP更常用于因严重青光眼导致视力潜力有限的眼睛。严重并发症包括严重视力丧失、炎症、低眼压和眼球痨。ECP较晚用于难治性青光眼的治疗。与间接睫状体破坏手术TCP相比,ECP能够在直视下特异性地靶向睫状体上皮。文献表明,ECP用于成人青光眼时总体成功率较高,并发症发生率相对较低。使用MP-TCP的新技术是传统睫状体光凝术的一种有前景的替代方法。早期证据表明,MP-TCP具有临床应用价值且安全性良好。超声睫状体成形术是激光睫状体破坏术的一种可能替代方法,已实现商业化,目前正在研究中。
TCP和ECP都是有效的睫状体破坏手术,是药物和手术治疗无效的青光眼的替代治疗方法,尽管存在严重并发症的风险。TCP、ECP和超声睫状体成形术越来越多地被用作各种类型和阶段青光眼的主要手术方法。